Use of Health Care Databases to Support Supplemental Indications of Approved Medications.
Abstract
Importance null Manufacturers of US Food and Drug Administration–approved prescription drugs often apply for additional indications based on randomized clinical trials. Real-world database analyses on a medication’s use and outcomes in routine settings of care might help to inform decision making regarding such supplemental indications. null Objective null To examine whether longitudinal data from a health care database can support the results...
Paper Details
Title
Use of Health Care Databases to Support Supplemental Indications of Approved Medications.
Published Date
Jan 1, 2018
Journal
Volume
178
Issue
1
Pages
55 - 63
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History